Cargando…
Targeting type 2 inflammation in bullous pemphigoid: current and emerging therapeutic approaches
Bullous pemphigoid (BP) is one of the most common autoimmune bullous diseases and mainly affects an elderly population with multi-morbidity. Due to the frailty of many BP patients, existing treatment options are limited. The blisters associated with BP result from IgG and IgE autoantibodies binding...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442825/ https://www.ncbi.nlm.nih.gov/pubmed/37614956 http://dx.doi.org/10.3389/fmed.2023.1196946 |